UY34420A - ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos" - Google Patents

?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"

Info

Publication number
UY34420A
UY34420A UY0001034420A UY34420A UY34420A UY 34420 A UY34420 A UY 34420A UY 0001034420 A UY0001034420 A UY 0001034420A UY 34420 A UY34420 A UY 34420A UY 34420 A UY34420 A UY 34420A
Authority
UY
Uruguay
Prior art keywords
ribavirine
hepatitis
virus
compositions
treatment
Prior art date
Application number
UY0001034420A
Other languages
English (en)
Inventor
Berrey Miriam Michelle
Robert G Hindes
William T Symonds
Adrian S Ray
Mo Hongmei
Christy M Hebner
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/055621 external-priority patent/WO2013040492A2/en
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Publication of UY34420A publication Critical patent/UY34420A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe un método para tratar una infección por el virus de la hepatitis C que comprende administrarle al paciente GS-7977 y ribavirina. En un aspecto, el método comprende la administración al sujeto de un régimen de tratamiento libre de interferón que comprende GS-7977 y ribavirina. También se describe en la presente una composición útil para el tratamiento de la infección por virus de la hepatitis C, dicha composición comprende GS-7977 y ribavirina, así como el uso de dichos compuestos para preparar un medicamento para tratar una infección por el virus de la hepatitis C.
UY0001034420A 2011-10-31 2012-10-30 ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos" UY34420A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161553481P 2011-10-31 2011-10-31
US201161564500P 2011-11-29 2011-11-29
PCT/US2012/055621 WO2013040492A2 (en) 2011-09-16 2012-09-14 Methods for treating hcv
US201261707459P 2012-09-28 2012-09-28

Publications (1)

Publication Number Publication Date
UY34420A true UY34420A (es) 2013-05-31

Family

ID=48173020

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034420A UY34420A (es) 2011-10-31 2012-10-30 ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"

Country Status (10)

Country Link
EP (1) EP2776024A1 (es)
JP (1) JP2014532657A (es)
CN (1) CN104244947A (es)
AR (1) AR088580A1 (es)
AU (1) AU2012332827A1 (es)
BR (1) BR112014010295A2 (es)
CA (1) CA2853495A1 (es)
TW (1) TW201318627A (es)
UY (1) UY34420A (es)
WO (1) WO2013066748A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116087C2 (uk) 2011-09-16 2018-02-12 Гіліад Фармассет Елелсі Композиція для лікування вірусу гепатиту c
KR20140119012A (ko) 2013-01-31 2014-10-08 길리어드 파마셋 엘엘씨 두 항바이러스 화합물의 병용 제형물
EP2959891A1 (en) * 2014-06-23 2015-12-30 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release pharmaceutical compositions of sofosbuvir and ribavirin
US20170151272A1 (en) * 2014-06-23 2017-06-01 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A novel pharmaceutical composition of sofosbuvir and ribavirin
EA201692507A1 (ru) * 2014-06-23 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. Фармацевтические комбинации софосбувира и рибавирина
RS62434B1 (sr) 2014-12-26 2021-11-30 Univ Emory Antivirusni n4-hidroksicitidin derivati
CZ2015443A3 (cs) * 2015-06-26 2017-01-04 Zentiva, K.S. Farmaceutická formulace sofosbuviru
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物
CN111372592A (zh) 2017-12-07 2020-07-03 埃默里大学 N4-羟基胞苷及衍生物和与其相关的抗病毒用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530901A (en) 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
CA2699280A1 (en) 2007-09-14 2009-03-26 Schering Corporation Method of treating hepatitis c patients
TWI583692B (zh) 2009-05-20 2017-05-21 基利法瑪席特有限責任公司 核苷磷醯胺
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
US20120107278A1 (en) 2010-10-29 2012-05-03 Pharmasset, Inc. Abbreviated hcv therapy for hcv infected patients with il28b c/c genotype
CA2830112A1 (en) * 2011-03-31 2012-10-04 F. Hoffmann-La Roche Ag Selection of hcv treatment

Also Published As

Publication number Publication date
EP2776024A1 (en) 2014-09-17
JP2014532657A (ja) 2014-12-08
AR088580A1 (es) 2014-06-18
CA2853495A1 (en) 2013-05-10
AU2012332827A1 (en) 2014-05-15
TW201318627A (zh) 2013-05-16
CN104244947A (zh) 2014-12-24
BR112014010295A2 (pt) 2017-04-18
WO2013066748A1 (en) 2013-05-10

Similar Documents

Publication Publication Date Title
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
IL244431A0 (en) Pharmacy methods and preparations for the treatment of hepatitis b virus infection
PH12016500486A1 (en) Aza-pyridone compounds and uses thereof
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
PH12017500207A1 (en) Indoles for use in influenza virus infection
MD20140035A2 (ro) Metodă de tratament al hepatitei virale C
DK2935303T3 (da) 4`-fluornukleosider, 4`-fluornukleotider og analoger dertil til behandling af HCV
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
MX2016008448A (es) Conjugados de var2csa-farmaco.
UY35661A (es) Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que lo s contienen
PH12015502588B1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
UA113956C2 (xx) Похідні піримідину для лікування вірусних інфекцій
PH12016500492A1 (en) Pyridazinone compounds and uses thereof
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
CL2015002897A1 (es) Inhibidores de bace1
PH12016500465B1 (en) Deoxynojirimycin derivatives and methods of their using
CL2016000300A1 (es) Métodos terapéuticos
UY34695A (es) Vacuna de herpesvirus-1 equino recombinante que contiene glicoproteína c mutada y usos de la misma
GB201213484D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods of using the same
PH12017500820A1 (en) Combination long acting compositions and methods for hepatitis c
PH12017500816A1 (en) Long acting pharmaceutical compositions for hepatitis c
TN2013000397A1 (en) Treatment of hepatitis c virus infection with alisporivir
TH148347B (th) "ส่วนประกอบสารต้านอนุมูลอิสระที่มีปริมาณแคลอรีต่ำ, กระบวนการได้สิ่งดังกล่าวมา และการใช้สิ่งดังกล่าว"

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200623